General Announcement::ASX:TLX; Nasdaq:TLX: Telix Completes FAP-Targeting Theranostic Acquisition

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
12-Mar-2025 05:54:56
Status
New
Announcement Sub Title
ASX:TLX; Nasdaq:TLX: Telix Completes FAP-Targeting Theranostic Acquisition
Announcement Reference
SG250312OTHR8ZK4
Submitted By (Co./ Ind. Name)
Genevieve Ryan
Designation
Company Secretary
Effective Date and Time of the event
12/03/2025 17:00:00
Description (Please provide a detailed description of the event in the box below)
ASX:TLX; Nasdaq:TLX: Telix Completes FAP-Targeting Theranostic Acquisition

Attachments

20250312 Project Magnolia Close vFINAL.pdf
Total size =135K